Investor Perspectives – How to Solve the Biotech/Life Sciences Problem: Changes Expected in the Sector in the Coming 12 Months

This is Investor Perspectives. I'm the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding. In our new Investor Perspectives series entitled "How to Solve the Biotech/Life Sciences Problem", you'll hear about changes expected in the Biotech/Life Sciences sector in the coming 12 months. As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up. Our guests are: Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels 01:16Carter Williams, CEO and Managing Partner, iSelect Fund 05:08Maximilian Bade, Founding Partner, Nucleus Capital 12:06Ron Paliwoda, President, Paliwoda Group 15:44Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund 24:21Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures 27:28Mark Groper, Chief Executive Officer, Orion Biotechnology 30:22 We hope you enjoy the show. _______________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https://tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact [email protected] Music courtesy of Bensound